It is designed for patients who are considering or currently using this medication
Clinical trials demonstrate average weight reductions of approximately 15% with semaglutide 2.4 mg (STEP 1 trial) and 20-22.5% with tirzepatide 10-15 mg (SURMOUNT-1 trial) over 68-72 weeks
Complete the online medical intake accurately, including current weight, health history, allergies and medications
These genetic predispositions do not predict exact medication response, but they may help your provider understand your baseline metabolic risk and inform discussions about semaglutide efficacy and safety
At LifeRx.md, weight loss plans are medically guided, personalized to your metabolism and goals, and built around long-term sustainabilitynot temporary hunger tricks or extreme food restriction
De Souza JB, De Lacerda Coriolano D, Dos Santos Silva RC, Da Costa Jnior SD, De Almeida Campos LA, Cavalcanti IDL, Lira Nogueira MCDB, Pereira VRA, Brelaz-de-Castro MCA, Cavalcanti IMF